Insmed, Inc. (INSM)
146.17
-2.26
(-1.52%)
USD |
NASDAQ |
Feb 12, 16:00
146.00
-0.17
(-0.12%)
After-Hours: 20:00
Insmed Cash from Investing (Quarterly) : -762.23M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 501.11M |
| Biogen, Inc. | -1.232B |
| CorMedix, Inc. | -291.32M |
| Merck & Co., Inc. | -- |
| Pfizer Inc. | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -219.76M |
| Cash from Financing (Quarterly) | 33.41M |
| Free Cash Flow | -906.14M |
| Free Cash Flow Per Share (Quarterly) | -1.049 |
| Free Cash Flow to Equity (Quarterly) | -223.92M |
| Free Cash Flow to Firm (Quarterly) | -201.72M |
| Free Cash Flow Yield | -3.26% |